CIK 0001521036
- Large accelerated filer
Lantheus Holdings, Inc.
Sign in to watch- Ticker
- LNTH
- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 352318913
- Phone
- +1 978-671-8001
- Business address
- 201 BURLINGTON ROAD, SOUTH BUILDING, BEDFORD, MA, 01730
- Former names
- Lantheus MI Holdings, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-03-03 | Sabens Andrea Chief Accounting Officer | Grant or award | +7,099 | 71,331 | ||
| 2023-03-03 | Heino Mary Anne President & CEO | Grant or award | +74,486 | 823,705 | ||
| 2023-03-03 | Heino Mary Anne President & CEO | Sale | −64,658 | $72.90 | $4.7M | 759,047 |
| 2023-03-03 | Heino Mary Anne President & CEO | Sale | −17,397 | $73.35 | $1.3M | 741,650 |
| 2023-03-02 | Marshall Robert J. Jr. CFO and Treasurer | Grant or award | +20,283 | 141,348 | ||
| 2023-03-02 | Marshall Robert J. Jr. CFO and Treasurer | Grant or award · Stock Option (right to buy) | +11,822 | 11,822 | ||
| 2023-03-02 | Montagut Etienne Chief Business Officer | Grant or award | +13,968 | 92,643 | ||
| 2023-03-02 | Montagut Etienne Chief Business Officer | Grant or award · Stock Option (right to buy) | +8,141 | 8,141 | ||
| 2023-03-02 | Provost Jean-Claude Chief Medical Officer | Grant or award | +16,359 | 20,823 | ||
| 2023-03-02 | Provost Jean-Claude Chief Medical Officer | Grant or award · Stock Option (right to buy) | +9,535 | 9,535 | ||
| 2023-03-02 | Niedzwiecki Daniel See Remarks | Grant or award · Stock Option (right to buy) | +7,196 | 7,196 | ||
| 2023-03-02 | Blanchfield Paul Chief Operating Officer | Grant or award | +20,383 | 94,351 | ||
| 2023-03-02 | Blanchfield Paul Chief Operating Officer | Grant or award · Stock Option (right to buy) | +11,880 | 11,880 | ||
| 2023-03-02 | Sabens Andrea Chief Accounting Officer | Grant or award | +3,772 | 64,232 | ||
| 2023-03-02 | Sabens Andrea Chief Accounting Officer | Grant or award · Stock Option (right to buy) | +1,936 | 1,936 | ||
| 2023-03-02 | Heino Mary Anne President & CEO | Grant or award | +76,686 | 749,219 | ||
| 2023-03-02 | Heino Mary Anne President & CEO | Grant or award · Stock Option (right to buy) | +44,696 | 44,696 | ||
| 2023-02-15 | Sabens Andrea Chief Accounting Officer | Sale | −386 | $57.52 | $22K | 60,460 |
| 2023-01-17 | Sabens Andrea Chief Accounting Officer | Sale | −386 | $52.97 | $20K | 60,846 |
| 2022-12-15 | Sabens Andrea Chief Accounting Officer | Sale | −386 | $53.75 | $21K | 61,232 |
Page 17 of 19 · 376 trades